Image
Mini Curriculum

Evolving Approaches to Alzheimer’s Disease

Finding the Way Forward

Suggested Readings

The future of anti-amyloid trials.

Aisen PS, Cummings J, Doody R, et al. J Prev Alzheimers Dis. 2020;7(3):146-151.

2021 Alzheimer’s disease facts and figures.

Alzheimer’s Association.

Neuropathological stageing of Alzheimer-related changes.

Braak H, Braak E. Acta Neuropathol. 1991;82(4):239-259.

EMERGE and ENGAGE topline results: two phase 3 studies to evaluate aducanumab in patients with early Alzheimer’s disease.

Budd Haeberlein S, von Hehn C, Tian Y, et al. Presented at: 12th Clinical Trials on Alzheimer’s Disease; December 4-7, 2019; San Diego, CA.

Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment.

Chandra A, Dervenoulas G, Politis M. J Neurol. 2019;266(6):1293-1302.

Biomarkers for Alzheimer's disease. Where we stand and where we are headed.

Chrem Méndez P, Surace E, Bérgamo Y, et al. Medicina (B Aires). 2019;79(Spec 6/1):546-551.

Imaging and molecular mechanisms of Alzheimer's disease: a review.

Femminella GD, Thayanandan T, Calsolaro V, et al. Int J Mol Sci. 2018;19(12):3702.

Costly new Alzheimer disease medications on the horizon—financing alternatives for Medicare.

Fleming WK, Brown CR, Shrank WH. JAMA Health Forum. 2020;1(9):e201148.

Pharmacotherapy of Alzheimer's disease: seeking clarity in a time of uncertainty.

Husna Ibrahim N, Yahaya MF, Mohamed W, et al. Front Pharmacol. 2020;11:261.

A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers.

Jack CR Jr, Bennett DA, Blennow K, et al. Neurology. 2016;87(5):539-547.

The diagnosis and management of mild cognitive impairment: a clinical review.

Langa KM, Levine DA. JAMA. 2014;312(23):2551-2561.

Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older.

Larson EB, Wang L, Bowen JD, et al. Ann Intern Med. 2006;144(2):73-81.

Risk factors for predicting progression from mild cognitive impairment to Alzheimer's disease: a systematic review and meta-analysis of cohort studies.

Li JQ, Tan L, Wang HF, et al. J Neurol Neurosurg Psychiatry. 2016;87(5):476-484.

Donanemab in early Alzheimer's disease.

Mintun MA, Lo AC, Duggan Evans C, et al. N Engl J Med. 2021. Epub ahead of print.

A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease.

Panza F, Lozupone M, Logroscino G, Imbimbo BP. Nat Rev Neurol. 2019;15(2):73-88.

Increasing precision of clinical diagnosis of Alzheimer's disease using a combined algorithm incorporating clinical and novel biomarker data.

Sabbagh MN, Lue LF, Fayard D, Shi J. Neurol Ther. 2017;6(suppl 1):83-95.

Persistence of BAN2401-mediated amyloid reductions post-treatment: a preliminary comparison of amyloid status between the core phase of BAN2401-G000-201 and baseline of the open-label extension phase in subjects with early Alzheimer’s disease.

Swanson C, Zhang Y, Dhadda S, et al. Neurology. 2020;94(suppl 15):1330.

Potential new approaches for diagnosis of Alzheimer’s disease and related dementias.

Turner RS, Stubbs T, Davies DA, Albensi BC. Front Neurol. 2020;11:496.

What are the difficulties of implementing innovative pharmacy practice models in the care of patients with dementia?

Wimo A. Expert Rev Pharmacoecon Outcomes Res. 2021;21(1):1-4.

Economic burden of Alzheimer disease and managed care considerations.

Wong W. Am J Manag Care. 2020;26(suppl 8):S177-S183.

Relevant Resources

Reducing the Burden of Bipolar Depression

Improved Diagnostic and Management Strategies

Improving Outcomes in Bipolar Depression

Overcoming Diagnostic Challenges, Targeting Remission, and Optimizing Cardiometabolic Health

Comprehensive Management of Bipolar Depression

New Approaches to Optimizing Patient Outcomes

A Focus on Bipolar Depression

Overcoming Diagnostic Barriers and Optimizing Long-Term Patient Outcomes

Multidisciplinary Management of Bipolar Disorder

Accelerating Diagnosis, Achieving Remission, and Encouraging Adherence

Mixed Features in Depressive Episodes

Managing Patients Across the Disease Spectrum

Agitation and Psychiatric Disease

Best Practices for Emergency Care

Clinical Issues in Bipolar Depression

Consensus and Controversies Across the Spectrum of Patient Presentations